Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

FTRE

Fortrea Holdings Inc

Jun 20 • 04:00PM ET

5.32

Dollar change -0.13
Percentage change -2.39	%

Healthcare • Biotechnology • USA • NASD

Peers: PFE JNJ MRK AMGN LLY BMY GILD REGN VRTX BIIB

| Held by: IJR VTI VB VBR VXF CALF IJS SPSM IBB SLYV

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-8.57	Insider Own	0.42%	Shs Outstand	90.50M	Perf Week	-15.15%
Market Cap	481.46M	Forward P/E	7.06	EPS next Y	0.75	Insider Trans	-6.65%	Shs Float	90.12M	Perf Month	13.43%
Income	-770.80M	PEG	-	EPS next Q	0.08	Inst Own	102.38%	Short Float	14.93%	Perf Quarter	-39.34%
Sales	2.69B	P/S	0.18	EPS this Y	43.47%	Inst Trans	-1.93%	Short Ratio	4.46	Perf Half Y	-73.81%
Book/sh	9.49	P/B	0.56	EPS next Y	59.27%	ROA	-20.50%	Short Interest	13.46M	Perf Year	-77.89%
Cash/sh	1.12	P/C	4.74	EPS next 5Y	49.41%	ROE	-61.58%	52W Range	3.97 - 28.41	Perf YTD	-71.47%
Dividend Est.	-	P/FCF	3.32	EPS past 5Y	3.94%	ROIC	-39.17%	52W High	-81.27%	Beta	1.58
Dividend TTM	-	Quick Ratio	0.97	Sales past 5Y	1.11%	Gross Margin	17.12%	52W Low	34.01%	ATR (14)	0.50
Dividend Ex-Date	-	Current Ratio	0.97	EPS Y/Y TTM	-527.14%	Oper. Margin	-3.82%	RSI (14)	49.94	Volatility	2.37% 5.71%
Employees	15500	Debt/Eq	1.50	Sales Y/Y TTM	-10.69%	Profit Margin	-28.70%	Recom	3.08	Target Price	5.97
Option/Short	Yes / Yes	LT Debt/Eq	1.29	EPS Q/Q	-451.75%	Payout	-	Rel Volume	1.44	Prev Close	5.45
Sales Surprise	7.01%	EPS Surprise	137.04%	Sales Q/Q	-1.63%	Earnings	May 12 BMO	Avg Volume	3.02M	Price	5.32
SMA20	6.36%	SMA50	1.19%	SMA200	-62.31%	Trades		Volume	4,333,927	Change	-2.39%

Date	Action	Analyst	Rating Change	Price Target Change
May-02-25	Initiated	Truist	Hold	$7
Apr-10-25	Downgrade	Barclays	Equal Weight → Underweight	$6
Dec-11-24	Downgrade	Citigroup	Buy → Neutral	$30 → $23
Dec-06-24	Downgrade	Robert W. Baird	Outperform → Neutral	$28 → $25
Sep-25-24	Downgrade	Jefferies	Buy → Hold	$25 → $21
Aug-08-24	Downgrade	Evercore ISI	Outperform → In-line	$31 → $27
Jul-24-24	Resumed	Barclays	Equal Weight	$30
Jun-06-24	Initiated	Goldman	Neutral	$28
May-29-24	Initiated	TD Cowen	Hold	$27
May-28-24	Initiated	Mizuho	Neutral	$27
Mar-22-24	Initiated	Robert W. Baird	Neutral	$43
Mar-06-24	Initiated	Deutsche Bank	Hold	$36
Jan-05-24	Initiated	William Blair	Mkt Perform
Jan-04-24	Initiated	Jefferies	Buy	$44
Dec-11-23	Upgrade	Citigroup	Neutral → Buy	$34 → $40
Dec-01-23	Upgrade	Evercore ISI	In-line → Outperform	$32 → $36
Nov-14-23	Upgrade	Barclays	Equal Weight → Overweight	$29 → $38
Oct-19-23	Initiated	Citigroup	Neutral	$32
Sep-14-23	Initiated	Evercore ISI	In-line	$31
Aug-16-23	Initiated	Barclays	Equal Weight	$29

Show Previous Ratings

Jun-20-25 11:40AM	FTRE vs. ILMN: Which Stock Should Value Investors Buy Now? (Zacks)
Jun-16-25 11:38PM	Drug Development Inputs & Services Stocks Q1 Recap: Benchmarking Fortrea (NASDAQ:FTRE) (StockStory) -5.70%
Jun-13-25 12:15PM	Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz (TipRanks) -5.74%
Jun-12-25 08:36AM	Fortrea Adopts Limited-Duration Stockholder Rights Plan (GlobeNewswire) +15.47%
Jun-11-25 04:10PM	Fortrea Names Anshul Thakral Chief Executive Officer (GlobeNewswire)
09:35AM	Loading…
Jun-04-25 09:35AM	FTRE Q1 CY2025 Earnings Call: Revenue Miss, Adjusted Profit Beat, and CEO Transition (StockStory) +12.96%
Jun-03-25 04:05PM	Fortrea to Present at the Jefferies Global Healthcare Conference (GlobeNewswire) +12.11%
May-30-25 12:00AM	Fortrea (FTRE): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
May-13-25 03:05AM	Fortrea Holdings Inc (FTRE) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
May-12-25 06:03PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) -15.61%
07:50AM	Fortrea Holdings Inc. (FTRE) Q1 Earnings and Revenues Beat Estimates (Zacks)
06:40AM	Fortrea Reports First Quarter 2025 Results (GlobeNewswire)
06:30AM	Fortrea Announces CEO Stepping Down (GlobeNewswire)
May-09-25 12:37AM	3 Volatile Stocks Skating on Thin Ice (StockStory)
May-08-25 06:00PM	Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates (Zacks) +5.68%
10:00AM	Loading…
May-07-25 10:00AM	Earnings Preview: Oculis Holding AG (OCS) Q1 Earnings Expected to Decline (Zacks)
May-05-25 10:00AM	Analysts Estimate Fortrea Holdings Inc. (FTRE) to Report a Decline in Earnings: What to Look Out for (Zacks) -5.27%
09:46AM	Fortrea: 83% Price Drop, Low Gross Margin, Declining Revenues - Not Yet An Opportunity (Seeking Alpha)
May-01-25 07:00AM	Fortrea Named a Leader in Everest Group's Pharmacovigilance Operations PEAK Matrix Assessment 2025 (GlobeNewswire)
12:32AM	3 Small-Cap Stocks Skating on Thin Ice (StockStory)
Apr-15-25 07:00AM	Fortrea Announces Date for First Quarter 2025 Financial Results and Conference Call (GlobeNewswire) -9.33%
Apr-13-25 10:44AM	The 1-Minute Market Report April 13, 2025 (Seeking Alpha)
Mar-31-25 08:05AM	The 1-Minute Market Report March 30, 2025 (Seeking Alpha) -5.98%
Mar-25-25 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Fortrea and Ibotta and Encourages Investors to Contact the Firm (GlobeNewswire) -7.02%
Mar-20-25 08:07PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) -5.29%
Mar-18-25 05:04AM	Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE) (StockStory)
Mar-04-25 02:02AM	Fortrea Holdings Inc (FTRE) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com) +5.59%
01:04AM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research)
Mar-03-25 06:45AM	Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance (GlobeNewswire) -25.05%
Feb-21-25 03:33PM	Fortrea to Add Erin L. Russell to Board of Directors (GlobeNewswire)
07:00AM	Loading…
Feb-20-25 07:00AM	Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research (GlobeNewswire)
Feb-06-25 07:17PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research)
Jan-30-25 07:00AM	Fortrea Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call (GlobeNewswire)
Dec-07-24 05:15AM	Fortrea downgraded to Neutral from Outperform at Baird (TipRanks)
Dec-05-24 04:05PM	Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors (GlobeNewswire) -8.06%
Nov-26-24 04:15PM	Fortrea to Present at the Evercore HealthCONx Conference (GlobeNewswire)
04:15PM	Fortrea to Present at the Citi Global Healthcare Conference (GlobeNewswire)
Nov-12-24 06:45AM	Fortrea price target raised to $30 from $28 at Baird (TipRanks)
Nov-11-24 12:31PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research)
Nov-09-24 02:04AM	Fortrea Holdings Inc (FTRE) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing ... (GuruFocus.com)
Nov-08-24 10:15AM	Fortrea Stock Explodes 37%--Investors Are Eyeing Massive Gains (GuruFocus.com) +30.19%
06:30AM	Fortrea Reports Third Quarter 2024 Results (GlobeNewswire)
Oct-17-24 07:00AM	Fortrea Releases Inaugural Corporate Social Responsibility Report (GlobeNewswire)
Oct-14-24 07:00AM	Fortrea Announces Date for Third Quarter 2024 Financial Results and Conference Call (GlobeNewswire)
Aug-13-24 12:58PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) +10.88%
Aug-12-24 07:04PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) -20.35%
07:00AM	Fortrea Reports Second Quarter 2024 Results (GlobeNewswire)
Jul-17-24 07:00AM	Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call (GlobeNewswire)
Jul-11-24 08:42AM	Do Options Traders Know Something About Fortrea (FTRE) Stock We Don't? (Zacks) +5.36%
08:00AM	Fortrea Appoints Robert Parks as Chief Accounting Officer (GlobeNewswire)
Jun-27-24 07:00AM	Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery (GlobeNewswire)
Jun-19-24 05:02PM	Fortrea to Participate in Virtual Fireside Chat with Evercore ISI (GlobeNewswire)
Jun-04-24 07:00AM	Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners (GlobeNewswire)
Jun-03-24 07:00AM	Fortrea to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-30-24 07:01PM	Fortrea Holdings Inc (FTRE) CEO Acquires Additional Shares (GuruFocus.com)
07:00AM	Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research (GlobeNewswire)
May-21-24 09:48AM	Seth Klarman 2024 Portfolio: Top New Stock Picks (Insider Monkey)
May-17-24 10:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
May-16-24 04:05PM	Fortrea Appoints Machelle Sanders to Board of Directors (GlobeNewswire)
May-15-24 03:56PM	Klarman's Baupost Group Buys Stake in SoundHound, Cuts Position in Warner Bros Discovery (Investopedia)
May-14-24 06:43PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research)
03:01AM	Fortrea Holdings Inc (FTRE) (Q1 2024) Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-13-24 06:50PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) -14.90%
10:52AM	FTRE Stock Earnings: Fortrea Holdings Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:30AM	Fortrea Reports First Quarter 2024 Results (GlobeNewswire)
May-06-24 08:22AM	Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference Call (GlobeNewswire)
Apr-30-24 01:58PM	Laboratory Corporation of America Holdings (NYSE:LH) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-11-24 07:00AM	Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call (GlobeNewswire)
Mar-12-24 11:24AM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research)
Mar-11-24 06:30AM	Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners (GlobeNewswire)
06:30AM	Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance (GlobeNewswire)
Feb-20-24 04:05PM	Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx Expansion (GlobeNewswire)
07:00AM	Fortrea to Present at the Barclays 26th Annual Global Healthcare Conference (GlobeNewswire)
Jan-29-24 07:00AM	Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call (GlobeNewswire)
Jan-09-24 04:22PM	Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial Experience (GlobeNewswire)
Jan-08-24 07:00AM	Fortrea Previews J.P. Morgan Healthcare Conference Updates (GlobeNewswire)
Jan-05-24 04:53AM	Vltava Fund Sold Fortrea Holdings (FTRE) for an Attractive Price (Insider Monkey)
Jan-04-24 08:00AM	FORTREA SELECTS COGNIZANT AS ITS TECHNOLOGY TRANSFORMATION PROVIDER (PR Newswire)
Jan-02-24 07:00AM	Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-13-23 07:00AM	Fortrea Convenes New Site Advisory Board (GlobeNewswire)
Nov-20-23 07:00AM	Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials (GlobeNewswire)
Nov-14-23 08:33PM	Analyst Report: Fortrea Holdings Inc. (Morningstar Research) +5.05%
Nov-13-23 11:07AM	Fortrea Holdings Inc (FTRE) Reports Mixed Q3 Results Amidst Transformation (GuruFocus.com) +9.61%
06:30AM	Fortrea Reports Third Quarter 2023 Results (GlobeNewswire)
Nov-02-23 07:00AM	Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K. (GlobeNewswire)
Oct-18-23 05:40AM	Here's Why Madison Mid Cap Fund Elected to Sell Fortrea Holdings (FTRE) (Insider Monkey)
Oct-17-23 01:35PM	Hedge Fund and Insider Trading News: John Paulson, Ray Dalio, Starboard Value, Trian Fund Management, ExodusPoint Capital Management, JAT Capital, Lexicon Pharmaceuticals, Inc. (LXRX), Omnicom Group Inc. (OMC), and More (Insider Monkey)
09:05AM	Starboard Value Issues Presentation Delivered at 13D Monitors 2023 Active-Passive Investor Summit (Business Wire)
Oct-16-23 08:30PM	Starboard Takes 5%-Plus Stake in Contract-Research Firm Fortrea (The Wall Street Journal)
Oct-13-23 07:00AM	Fortrea Appoints Life Science Executive Dr. John Doyle to Lead Consulting Team (GlobeNewswire)
Oct-11-23 07:00AM	Fortrea Announces Date for Third Quarter 2023 Financial Results and Conference Call (GlobeNewswire)
Oct-10-23 07:00AM	Fortrea's Jim Cameli Named a Top 100 Global Chief Information Security Officer by HotTopics (GlobeNewswire)
Oct-06-23 04:52AM	Here's Why Vltava Fund Sold Fortrea Holdings (FTRE) (Insider Monkey)
Sep-15-23 08:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Sep-06-23 11:00AM	Fortrea to Present at the Morgan Stanley 21st Annual Global Healthcare Conference (GlobeNewswire)
11:00AM	Fortrea to Present at the Baird 2023 Global Healthcare Conference (GlobeNewswire)
Aug-16-23 10:00AM	Chevron upgraded, SolarEdge downgraded: Wall Street's top analyst calls (The Fly)
Aug-15-23 07:03AM	Fortrea: The Number One Hurdle to Focus on Now Is Growth (GuruFocus.com)
07:03AM	Fortrea: The Main Hurdle to Focus on Now Is Growth (GuruFocus.com)
Aug-14-23 07:00AM	Fortrea Reports Second Quarter 2023 Results and Provides Full-Year 2023 Guidance (GlobeNewswire) -12.21%

Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments. The Clinical Services segment provides services across the clinical pharmacology, clinical development, and other clinical service spectrum utilizing enabling services and technology through multiple delivery models. The Enabling Services segment provides technology solutions directly to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. The company was founded on January 31, 2023 and is headquartered in Durham, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Morais Mark A.	Chief Operating Officer	Jun 02 '25	Option Exercise	0.00	11,007	0	49,679	Jun 04 05:44 PM
Morais Mark A.	Chief Operating Officer	Jun 03 '25	Sale	4.17	3,130	13,052	46,549	Jun 04 05:44 PM
Mcconnell Jill G.	Chief Financial Officer	Jun 02 '25	Option Exercise	0.00	11,007	0	51,474	Jun 04 05:43 PM
Mcconnell Jill G.	Chief Financial Officer	Jun 03 '25	Sale	4.17	3,130	13,052	48,344	Jun 04 05:43 PM
Hanson James S.	General Counsel	Jun 02 '25	Option Exercise	0.00	7,706	0	17,172	Jun 04 05:42 PM
Hanson James S.	General Counsel	Jun 03 '25	Sale	4.17	2,191	9,136	14,981	Jun 04 05:42 PM
Mcconnell Jill G.	Officer	Jun 03 '25	Proposed Sale	4.17	3,130	13,050		Jun 03 03:25 PM
Morais Mark A.	Officer	Jun 03 '25	Proposed Sale	4.17	3,130	13,050		Jun 03 03:23 PM
Hanson James S.	Officer	Jun 03 '25	Proposed Sale	4.17	2,191	9,135		Jun 03 03:15 PM
Smith David Ross	Director	May 14 '25	Option Exercise	0.00	7,282	0	11,729	May 16 04:51 PM
Pesicka Edward A	Director	May 14 '25	Option Exercise	0.00	7,282	0	13,636	May 16 04:49 PM
Ray Amrit	Director	May 14 '25	Option Exercise	0.00	7,282	0	13,636	May 16 04:47 PM
SANDERS MACHELLE	Director	May 14 '25	Option Exercise	0.00	7,282	0	7,282	May 16 04:45 PM
NEUPERT PETER M	Chief Executive Officer	May 14 '25	Option Exercise	0.00	7,282	0	35,632	May 16 04:42 PM
Hanson James S.	General Counsel	Mar 13 '25	Option Exercise	0.00	2,998	0	10,473	Mar 17 04:37 PM
Hanson James S.	General Counsel	Mar 14 '25	Sale	9.70	1,007	9,768	9,466	Mar 17 04:37 PM
Morais Mark A.	Chief Operating Officer	Mar 13 '25	Option Exercise	0.00	4,283	0	39,879	Mar 17 04:35 PM
Morais Mark A.	Chief Operating Officer	Mar 14 '25	Sale	9.70	1,207	11,708	38,672	Mar 17 04:35 PM
Mcconnell Jill G.	Chief Financial Officer	Mar 13 '25	Option Exercise	0.00	4,283	0	41,677	Mar 17 04:33 PM
Mcconnell Jill G.	Chief Financial Officer	Mar 14 '25	Sale	9.70	1,210	11,737	40,467	Mar 17 04:33 PM
Morais Mark A.	Chief Operating Officer	Mar 12 '25	Option Exercise	0.00	725	0	35,799	Mar 14 04:32 PM
Morais Mark A.	Chief Operating Officer	Mar 13 '25	Sale	9.93	203	2,016	35,596	Mar 14 04:32 PM
Mcconnell Jill G.	Chief Financial Officer	Mar 12 '25	Option Exercise	0.00	935	0	37,655	Mar 14 04:31 PM
Mcconnell Jill G.	Chief Financial Officer	Mar 13 '25	Sale	9.93	261	2,592	37,394	Mar 14 04:31 PM
Hanson James S.	Officer	Mar 14 '25	Proposed Sale	9.70	1,007	9,766		Mar 14 03:40 PM
Morais Mark A.	Officer	Mar 14 '25	Proposed Sale	9.70	1,207	11,705		Mar 14 03:40 PM
Mcconnell Jill G.	Officer	Mar 14 '25	Proposed Sale	9.70	1,210	11,735		Mar 14 03:40 PM
Morais Mark A.	Chief Operating Officer	Mar 11 '25	Option Exercise	0.00	1,573	0	35,573	Mar 13 04:54 PM
Morais Mark A.	Chief Operating Officer	Mar 12 '25	Sale	9.98	499	4,980	35,074	Mar 13 04:54 PM
Mcconnell Jill G.	Chief Financial Officer	Mar 11 '25	Option Exercise	0.00	2,028	0	37,363	Mar 13 04:53 PM
Mcconnell Jill G.	Chief Financial Officer	Mar 12 '25	Sale	9.98	643	6,417	36,720	Mar 13 04:53 PM
Morais Mark A.	Officer	Mar 13 '25	Proposed Sale	9.93	203	2,015		Mar 13 03:18 PM
Mcconnell Jill G.	Officer	Mar 13 '25	Proposed Sale	9.93	261	2,591		Mar 13 03:15 PM
Morais Mark A.	Officer	Mar 12 '25	Proposed Sale	9.98	499	4,980		Mar 12 03:15 PM
Mcconnell Jill G.	Officer	Mar 12 '25	Proposed Sale	9.98	643	6,417		Mar 12 03:09 PM
ECKERT R ANDREW	Director	Feb 21 '25	Option Exercise	0.00	7,282	0	13,636	Feb 25 05:12 PM
Morais Mark A.	Chief Operating Officer	Feb 11 '25	Option Exercise	0.00	1,210	0	34,424	Feb 13 05:30 PM
Morais Mark A.	Chief Operating Officer	Feb 12 '25	Sale	14.67	424	6,220	34,000	Feb 13 05:30 PM
Mcconnell Jill G.	Chief Financial Officer	Feb 11 '25	Option Exercise	0.00	1,544	0	35,875	Feb 13 05:28 PM
Mcconnell Jill G.	Chief Financial Officer	Feb 12 '25	Sale	14.67	540	7,922	35,335	Feb 13 05:28 PM
Mcconnell Jill G.	Officer	Feb 12 '25	Proposed Sale	14.67	540	7,923		Feb 12 03:18 PM
Morais Mark A.	Officer	Feb 12 '25	Proposed Sale	14.67	424	6,221		Feb 12 03:15 PM
Mcconnell Jill G.	Chief Financial Officer	Feb 07 '25	Option Exercise	0.00	1,687	0	34,909	Feb 11 04:44 PM
Mcconnell Jill G.	Chief Financial Officer	Feb 10 '25	Sale	14.80	578	8,554	34,331	Feb 11 04:44 PM
Morais Mark A.	Chief Operating Officer	Feb 07 '25	Option Exercise	0.00	2,256	0	33,987	Feb 11 04:42 PM
Morais Mark A.	Chief Operating Officer	Feb 10 '25	Sale	14.80	773	11,440	33,214	Feb 11 04:42 PM
Morais Mark A.	Officer	Feb 10 '25	Proposed Sale	14.80	773	11,440		Feb 10 04:22 PM
Mcconnell Jill G.	Officer	Feb 10 '25	Proposed Sale	14.80	578	8,554		Feb 10 04:07 PM
Pike Thomas	Chief Executive Officer	Jan 10 '25	Option Exercise	0.00	40,220	0	171,136	Jan 14 06:08 PM
Pike Thomas	Chief Executive Officer	Jan 13 '25	Sale	18.04	11,268	203,275	159,868	Jan 14 06:08 PM
Pike Thomas	Officer	Jan 13 '25	Proposed Sale	18.04	11,268	203,288		Jan 13 03:12 PM
Morais Mark A.	Chief Operating Officer	Dec 15 '24	Option Exercise	0.00	406	0	31,910	Dec 17 05:18 PM
Morais Mark A.	Chief Operating Officer	Aug 19 '24	Option Exercise	0.00	11,312	0	36,464	Aug 20 05:37 PM
Mcconnell Jill G.	Chief Financial Officer	Aug 19 '24	Option Exercise	0.00	11,312	0	38,194	Aug 20 05:36 PM
Pike Thomas	Chief Executive Officer	Aug 19 '24	Option Exercise	0.00	125,691	0	183,518	Aug 20 05:34 PM
Smith David Ross	Director	Jul 18 '24	Option Exercise	0.00	6,354	0	6,354	Jul 19 05:24 PM
NEUPERT PETER M	Director	Jul 18 '24	Option Exercise	0.00	6,354	0	28,350	Jul 19 05:23 PM
Pesicka Edward A	Director	Jul 18 '24	Option Exercise	0.00	6,354	0	6,354	Jul 19 05:23 PM
ECKERT R ANDREW	Director	Jul 18 '24	Option Exercise	0.00	6,354	0	6,354	Jul 19 05:22 PM
Ray Amrit	Director	Jul 18 '24	Option Exercise	0.00	6,354	0	6,354	Jul 19 05:21 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

FTRE

Fortrea Holdings Inc

Upgrade your FINVIZ experience